Skip to main content

Featured Content

Mari Swingle, PhD, LMHC, explains why screen-based addiction has been misunderstood and whether COVID-19-related social distancing creates a heightened risk for excessive use and abuse of technology.
Braeburn has requested final approval from the U.S. Food and Drug Administration for Brixadi, an injectable form of buprenorphine with weekly and monthly formulations.
Fatal overdoses reported between January and April are up 11.4% compared to last year, and nonfatal overdoses are up 18.6%, with a spike that has coincided with the onset of the COVID-19 pandemic, according to data from ONDCP’s Overdose Data Mapping Application Program.
Use of high-potency marijuana was associated with an increased likelihood of cannabis problems and an increased likelihood of anxiety disorder, according to research recently published in JAMA Psychiatry.
Warriors Anonymous, a specialty meeting for active military, veterans, first responders and EMTs, has been created to strengthen peer network for “warriors” in recovery.

Meetings & Publications

Back to Top